Risk for Device Failure Similar With Different PICC Materials
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
THURSDAY, Jan. 9, 2025 -- For patients referred for peripherally inserted central catheters (PICCs), the risk for device failure is not lower with hydrophobic or chlorhexidine PICCs versus standard polyurethane ones, according to a study published in the Jan. 9 issue of the New England Journal of Medicine.
Amanda J. Ullman, Ph.D., from the University of Queensland in Brisbane, Australia, and colleagues conducted a randomized, controlled, superiority trial in three tertiary hospitals involving adults and children who were referred for PICC placement. Participants were randomly assigned to receive a hydrophobic or chlorhexidine PICC or a standard polyurethane PICC (365, 365, and 368, respectively) and were followed for eight weeks.
The researchers found that device failure occurred in 5.9, 9.9, and 6.1 percent of participants in the hydrophobic, chlorhexidine, and standard polyurethane groups, respectively (risk difference: hydrophobic versus standard polyurethane, −0.2 percentage points [95 percent confidence interval, −3.7 to 3.2; P = 0.89]; chlorhexidine versus standard polyurethane, 3.8 percentage points [95 percent confidence interval, −0.1 to 7.8; P = 0.06]). The odds ratio for device failure was 0.96 (95 percent confidence interval, 0.51 to 1.78) and 1.71 (95 percent confidence interval, 0.98 to 2.99) in the hydrophobic versus the standard-polyurethane group and in the chlorhexidine versus the standard-polyurethane group, respectively. Complications from any cause during the period of PICC placement occurred in 21.5, 38.6, and 21.7 percent in the hydrophobic, chlorhexidine, and standard-polyurethane groups, respectively.
"The current findings reflect the complexity in preventing multifactorial PICC dysfunction, with no apparent difference in the incidence of device failure or of catheter-acquired bloodstream infection according to PICC type," the authors write.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-01-10 06:00
Read more
- In Kids with Crohn's Disease, TNF Inhibitors Help Prevent Serious Complications, Data Suggests
- FDA Approves Ryoncil for Steroid-Refractory Acute Graft-Versus-Host After Allo-HSCT
- Blood Test Might Alert Doctors to Problem Drinking
- Telemedicine Not Reliable for Assessing Criteria for Acute Sore Throat
- FDA: Listeria Concerns Prompt Broccoli Recall at Walmart Stores
- Certain Foods May Cut Risk for Rheumatoid Arthritis
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions